Manufacturer
Jiangsu Hengrui Pharmaceuticals
Pharmaceutical manufacturer based in China
China
- Products listed
- 5
- Molecules
- 2
- Therapy areas
- 2
Jiangsu Hengrui Pharmaceuticals is a pharmaceutical manufacturer based in China. MedsAcross lists 5 of its products across 2 molecules, each with registers, packs and availability for export supply to licensed buyers.
- Country
- China
- Indian manufacturer
- No
- Also listed as
- Jiangsu Hengrui Pharmaceuticals Co., Ltd.
- US FDA labeler
- YesSource: openFDA NDC directory
Source from this manufacturer
We supply Jiangsu Hengrui Pharmaceuticals products through licensed channels, with the documents your regulator needs.
Oncology
3 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Docetaxel 160 mg/8 mL injectionIntravenousGeneric name | Docetaxel | US FDA | Available on request |
| Docetaxel 20 mg/1 mL injectionIntravenousGeneric name | Docetaxel | US FDA | Available on request |
| Docetaxel 80 mg/4 mL injectionIntravenousGeneric name | Docetaxel | US FDA | Available on request |
Pain and anaesthesia
2 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Bupivacaine 133 mg/10 mL liposomal injectable suspensionInfiltration Cold chainGeneric name | Bupivacaine | US FDA | Available on request |
| Bupivacaine 266 mg/20 mL liposomal injectable suspensionInfiltration Cold chainGeneric name | Bupivacaine | US FDA | Available on request |
Molecules made
Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.
Source from Jiangsu Hengrui Pharmaceuticals
Send a request for any of these products. We confirm the licensed source, documents and lead time.